Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$27.4M
-10.6% from 2023
Prescriptions
1,389
$19,746.75 per claim
Patients
330
370 prescribers
Total spending, 2024
$27.4M
$83,115.88 per patient
Medicare prescription drug plans paid $27.4M for Rydapt in 2024, for 1,389 prescriptions and refills to 330 patients (down 10.6% from 2023). The average cost per claim was $19,746.75.
California had the highest Medicare cost for Rydapt in 2024: $2.6M for 112 claims, followed by New Jersey ($1.8M).
Emily Q Chen, hematology-oncology in Trenton, NJ, had the highest Medicare cost for Rydapt in 2024: 19 claims costing $709K.
Rydapt is made by Novartis AG (NVS), listed in the Medicare spending data as Novartis.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Emily Q Chen Trenton, NJ | Hematology-Oncology | 19 | Under 11 | $709K |
| Isaac Tafur Lubbock, TX | Hematology-Oncology | 13 | Under 11 | $568K |
| Waheed Murad Temecula, CA |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 461 | 1,576 | 422 | $30.0M |
| 2023 | 401 | 1,404 | 346 | $30.7M |
| 2024 | 370 | 1,389 | 330 | $27.4M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Internal Medicine |
| 11 |
| Under 11 |
| $531K |
| Caleb J Scheckel Tulsa, OK | Hematology-Oncology | 25 | Under 11 | $495K |
| Emily A Diznoff Asheville, NC | General Practice | 11 | Under 11 | $447K |
| Parameswaren Venugopal Chicago, IL | Hematology-Oncology | 19 | Under 11 | $440K |
| Bobby Chawla Caldwell, ID | Hematology-Oncology | 12 | Under 11 | $406K |
| Daniel N Egan Seattle, WA | Hematology-Oncology | 18 | Under 11 | $388K |
| Brittany Gehm Denville, NJ | Nurse Practitioner | 14 | Under 11 | $340K |
| Jamal G Misleh Newark, DE | Hematology-Oncology | 14 | Under 11 | $317K |
| Sanjay R Mohan Nashville, TN | Hematology-Oncology | 24 | Under 11 | $300K |
| Yogenthiran Saunthararajah Cleveland, OH | Hematology | 15 | Under 11 | $294K |
| Snehal A Damle Suffolk, VA | Hematology-Oncology | 13 | Under 11 | $281K |
| John D Zubkus Murfreesboro, TN | Hematology-Oncology | 13 | Under 11 | $276K |
| Abhinav B Chandra Yuma, AZ | Hematology-Oncology | 19 | Under 11 | $274K |
| Peter H Sayre San Francisco, CA | Hematology-Oncology | 12 | Under 11 | $266K |
| John M Richart St Louis, MO | Hematology-Oncology | 12 | Under 11 | $262K |
| Michael J Keefer Oklahoma City, OK | Medical Oncology | 13 | Under 11 | $257K |
| Jessica J Slaba Sioux Falls, SD | Nurse Practitioner | 12 | Under 11 | $253K |
| Irene A Ryan Ann Arbor, MI | Physician Assistant | 11 | Under 11 | $240K |
| James K Mangan San Diego, CA | Hematology-Oncology | 11 | Under 11 | $239K |
| Roy L Kao Minneapolis, MN | Internal Medicine | 11 | Under 11 | $238K |
| Vathveal Mathews New York, NY | Nurse Practitioner | 12 | Under 11 | $236K |
| Elizabeth D Weiland Charleston, SC | Nurse Practitioner | 12 | Under 11 | $236K |
| Hetty Carraway Chagrin Falls, OH | Medical Oncology | 11 | Under 11 | $235K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Novartis NVS | 1,389 | $27.4M |